1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) is sponsored by National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH). This NOFO solicits applications for pilot projects to elucidate a role for understudied proteins in rare disease.
Awards will support generation of preliminary data and/or tools around eligible understudied protein(s) with the intent of elucidating the function of these proteins in the context of rare disease and obtaining sufficient preliminary data and/or research resources for subsequent grant applications and/or drug discovery projects.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligibility is broadly defined; see Section III. 3. Additional Information on Eligibility in the full announcement. Confirm the full requirements in the official notice before applying.
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) is funded by National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) (PAR-25-195) is sponsored by National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH). This limited-competition grant supports institutional postdoctoral research training and career development programs in clinical and translational science.
Clinical Trials on a Chip is sponsored by National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH). This program supports researchers using tiny, bioengineered models of human tissues and organ systems (tissue chips/organoids) to study diseases and test drugs, with the goal of improving clinical trial design and implementation. Adipose organoid models could be utilized to develop disease models relevant to metabolic diseases, drug testing, and toxicity assessment.
Advance from NIH SBIR Phase I to Phase II with tips on demonstrating feasibility, building a commercialization plan, and securing $1M in funding.
Read articlePAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read article